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Stigma reduction is an important public health challenge because of the large morbidity and 
mortality associated with some forms of substance use. Extreme stigma can lead to 
dehumanisation of target groups, who are ascribed with lesser humanity. We examined whether 
there was blatant and subtle dehumanisation of people who use heroin, and if these were 




A cross-sectional online study using a UK convenience sample (n = 307; 75.2% female, mean 
age 28.6 ± 12.2 years). Participants completed assessments of blatant (Ascent of Humans scale) 
and subtle (an emotion attribution task), dehumanisation, and a bespoke measure assessing 
support for non-discriminatory drug policies. Other measures controlled for stigma towards 
people who use drugs, and moral disgust. 
 
Findings 
There was greater blatant dehumanisation of people who used heroin compared to the general 
population and other potentially stigmatised reference groups, including people who use 
cannabis. We also found evidence of subtle dehumanisation, and people who used heroin were 
rated as being less likely to feel uniquely human emotions, less likely to feel positive emotions, 
and more likely to feel negative emotions. Blatant dehumanisation was associated with 
significantly lower probability of support for non-discriminatory drug policy. 
 
Originality 
This is the first study to investigate blatant and subtle dehumanisation of people who use 




Dehumanisation may present significant challenges for stigma reduction initiatives and in 
fostering public support for drug policy and treatment. Denial of the humanity of this group 
could be used to justify discriminatory policies or relative deprioritisation of support services 
in funding decisions. Activities that seek to ‘rehumanise’ people who use drugs, including 
social inclusion, and encouraging compassionate media representations that portray the lived 




People who use drugs (PWUD) are one of the most stigmatised groups in society, and are 
subject to more negative public attitudes and discrimination than other groups who are labelled 
by their experiences and conditions such as mental ill health, smoking, or obesity (Room et al., 
2001; Phillips and Shaw, 2013; Barry et al., 2019). Public stigma, and internalisation of 
negative attitudes by labelled groups (i.e. self-stigma) is associated with reduced health and 
social care uptake, poorer quality of care and outcomes, and reduced public support for 
supportive policies and services (Rivera et al., 2014; Lancaster, Seear and Ritter, 2017; 
Andersen and Kessing, 2019). Negative outcomes can affect others such as family members of 
out-groups through processes of association (Dyregrov and Selseng, 2021), and this may also 
be internalised as affiliate stigma (Mak and Cheung, 2008), leading to concealment, isolation, 
and reductions in quality of life (Marshall, 2013). Considering the large mortality and 
morbidity burden associated with substance use (Degenhardt et al., 2018; Lewer et al., 2019) 
addressing stigma is an important public health challenge (McGinty and Barry, 2020).  
 
Models of stigma describe processes whereby an out-group is first identified by labelling on 
the basis of identifiable or perceived characteristics; subjected to stereotypes and prejudices; 
and then exposed to prejudice, discrimination and/or social distancing (Kilian et al., 2021). 
Stigma exists across the socio-ecological spectrum, and outcomes, experiences, practices, and 
drivers exist from individual to societal levels (Stangl et al., 2019).  There is an emerging body 
of research that has identified determinants of public stigma towards PWUD, including media 
representations (e.g. Atkinson and Sumnall, 2021) the language used to describe affected 
groups (e.g. pejorative terms; Ashford et al., 2019); perceptions of blame, controllability, and 
culpability (e.g. substance use as a controllable choice; Sattler et al., 2017); personal 
characteristics of labelled groups (e.g. age, gender, parental status; Kulesza et al., 2016); and 
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the use of biogenetic explanations for underlying conditions (e.g. chronic relapsing condition; 
Kelly et al., 2021). Conversely, studies that have presented sympathetic and humanising 
narratives of PWUD (Bachhuber et al., 2015; Sumnall et al., 2020a; Sumnall et al., 2021) are 
associated with reduced public stigma, and increased support for policies benefiting PWUD, 
but only when associated with groups of higher socioeconomic status (Kennedy-Hendricks, 
Barry and McGinty, 2016) 
 
There has been relatively less research undertaken on the processes of stigmatisation of PWUD 
and how this may lead to discrimination and inequity in practice and policy responses (Kilian 
et al., 2021). One route may be through the dehumanisation of PWUD. Dehumanisation is a 
distinct concept from stigmatisation, but is often applied to the most highly stigmatised groups 
and refers to the absence of explicit attribution of human traits to out-groups (i.e., PWUD) 
compared to in-group members (i.e., the general public) (Kteily and Bruneau, 2017). This may 
lead to reduction of inter-group pro-social behaviours and increased social distancing from out-
group members (Martínez et al., 2017). The infrahumanisation theory of dehumanisation 
suggests that rather than blatant dehumanisation, subtle judgements made on the basis of 
perceptions of the relative differences in humanness between groups may be more common 
(Leyens et al., 2007). This is expressed through relative attribution of basic, primary emotions 
that both humans and animals share, and secondary emotions that are seen as unique indicators 
of humanity. Similarly, the two-dimensional model of humanness focuses on interpersonal and 
intergroup relations, and proposes that dehumanised outgroups are denied unique traits and 
attributes of humanness such as emotional responsiveness, interpersonal warmth (prosociality), 
and depth (Haslam and Loughnan, 2014). This may also include a perceived lack of agency 
and human experience such as consciousness and personality in out-groups relative to in-
groups and non-human animals (Waytz et al., 2010). Neuroimaging studies suggest that there 
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may even be neuronal correlates to dehumanising perceptions, with exposure to pictorial 
representations of groups perceived to be low in warmth and competence such as PWUD or 
people who are homeless less likely to activate parts of the brain important in positive social 
cognitions (medial prefrontal cortex), and more likely to activate parts associated with 
emotional disgust (insula, amygdala) (Harris and Fiske, 2006; Harris and Fiske, 2009).  
 
Previous research has shown blatant and subtle dehumanisation towards a number of 
stigmatised groups, include people with severe alcohol use disorders (Fontesse, Rimez and 
Maurage, 2021), those with obesity (Kersbergen and Robinson, 2019), those who have 
experienced homelessness (Bruneau et al., 2018), refugees (Bruneau, Kteily and Laustsen, 
2018), and ethnic minority groups (Kteily and Bruneau, 2017). Blatant dehumanisation has 
been shown towards a range of people described as mentally ill, including those described as 
having ‘drug addiction' (Boysen et al., 2020). Whereas dehumanisation may be functional in 
some care-giving situations where high levels of emotional attachment to patients has been 
associated with staff burnout (Vaes and Muratore, 2013; Fontesse, Rimez and Maurage, 2021), 
in general, dehumanising attitudes are reflected in a higher desire for social distancing, 
perceptions of dangerousness, violence and victimisation, and higher levels of support for 
discriminatory and aggressive policies targeting out-groups (Rudman and Mescher, 2012; 
Kteily et al., 2015; Kersbergen and Robinson, 2019; Parker, Monteith and South, 2020).  
 
Dehumanisation of PWUD is apparent in popular media representations, particularly in visual 
imagery of ‘contaminated’ and ‘polluted’ bodies (Ayres and Jewkes, 2012), criminal 
‘mugshots’ (Fitzgerald, 2020; Atkinson and Sumnall, 2021), and drug consumption practices 
(e.g. a focus on injection) (Weimer, 2004); and in text narratives that omit pity and grieving 
for victims of drug-related deaths (Fraser, Farrugia and Dwyer, 2018), or emphasise the 
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dangerousness of PWUD and make comparison with fictional characters such as zombies 
(Alexandrescu, 2018; Atkinson and Sumnall, 2021). As with the internalisation of public 
stigmatising attitudes, the subjective perception of being dehumanised by others 
(metadehumanisation) has also been observed in people with alcohol use disorders and this is 
associated with dysfunctional coping strategies and the use of alcohol to cope (Fontesse et al., 
2020). 
 
In this study we investigated dehumanising attitudes towards people who use heroin in the 
general public. Whilst a large number of studies have examined the experiences and 
consequences of stigma in PWUD (for useful reviews see Lloyd, 2013; Lancaster et al., 2017)), 
few have specifically examined dehumanisation. Of those, and as described above, Fontesse 
and colleagues examined internalised dehumanisation in people with alcohol use disorders 
(2020) or attitudes of healthcare professionals towards this group (Fontesse, Rimez and 
Maurage, 2021), whilst Harris and Fiske (2006; 2009) primarily examined neural responses to 
visual stimuli of dehumanised groups. Based upon infrahumanisation theory and previous work 
undertaken with other highly stigmatised populations, we hypothesised that there would be 
both greater blatant and subtle dehumanisation towards people who use heroin compared with 
other stigmatised groups (e.g. people with serious mental health problems, obesity), and with 
people who use cannabis. We specifically chose heroin because this is a highly stigmatised 
drug associated with high mortality and morbidity, and within the general population, including 
within groups of PWUD, there are ‘hierarchies’ of substance use, with people using heroin 
viewed more negatively than those using drugs such as cannabis (McElrath and McEvoy, 2001; 
Palamar, Kiang and Halkitis, 2012; Brown, 2015). We also undertook an exploratory analysis 
to examine whether dehumanising attitudes were associated with stigma towards people who 





Online cross-sectional survey, and participants completed an anonymous online questionnaire.  
 
Participants 
A convenience sample was recruited from the UK general public. Inclusion criteria 
were people who were UK residents and aged over 18 years, and the questionnaire included 
screening checks. Participants were recruited through a number of methods, including students 
recruited internally for course credit, social media, and snowball sampling. To reduce bias, 
recruitment materials mentioned that this was a study investigating the decisions people make 
about substance use policy, but not that it was investigating dehumanisation or stigmatising 
attitudes, and this was only revealed in the survey debriefing. A priori power calculations were 
undertaken to estimate minimum sample sizes required for the two main analyses (see below) 
(G*Power 3.1; Faul et al. (2007)). To detect a medium effect size for the analysis of blatant 
dehumanisation (Friedman’s test), (f= 0.25, power 0.95; 10 measurements) an estimated a 
minimum sample size of 20 was required. Analysis of subtle dehumanisation was undertaken 
using a 2 x 2 x 4 repeated measures ANOVA, and to detect a medium effect size (f= 0.25, 
power 0.95) an estimated minimum sample size of 279 was required.  
 
Overall, 363 survey attempts were recorded, but only those participants providing complete 
data on both primary outcomes (blatant and subtle dehumanisation) were retained. The final 
sample comprised 307 participants (84.6% of attempts; n = 231 (75.2%) Female; mean age 
28.6 ± 12.2 years). Of relevance to study outcomes, 177 participants (57.7%) reported a lifetime 
use of a controlled drug (37.5% cannabis; 3.3% heroin); 7 (2.3%) had received structured drug 
 8 
treatment, and 59 (19.2%) had a family member of close friend who they believed had received 
support.  
 
Materials and Procedure 
Participants completed a single online questionnaire hosted on the Qualtrics platform 
(Qualtrics, Provo, UT, USA), and this took approximately 10 minutes to complete. All 
measures are described, but not all were included in the analyses reported here as our group 
utilises similar measures across different studies (e.g. media use, detailed patterns of substance 
use, demographics).  
 
After reading the study information and providing consent, participants completed two 
screening questions (UK resident; aged > 18 years) before proceeding. Participants completed 
questions on demographics (age, gender, education, ethnicity, employment); substance use 
history (lifetime and last year use of a number of substances); and voting preference to assess 
political orientation (main UK political parties; recoded into left; right; centre parties for 
analysis). 
 
Primary outcome measures 
Blatant dehumanisation was assessed using the Ascent of Humans (AoH) scale (Kteily et al., 
2015). This is a 100-point slider underneath a pictorial representation of five evolutionary 
stages between non-human primates and humans. Instructional text read “People can vary in 
how human-like they seem. Some people seem highly evolved, whereas others seem no different 
than lower animals. Using the image as a guide, indicate using the sliders how evolved you 
consider the average member of each group to be. Note: 'Brits' refers to citizens of the United 
Kingdom.” Participants were asked to rate on the scale how evolved they thought each of 11 
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groups was (including an attention check requesting the slider was moved all the way to the 
right). The target group for our study was Brits who use heroin (hereafter heroin); and 
comparison groups were Brits; Arabs; Brits who use cannabis; Brits with cancer; Mixed race 
Brits; Brits who are homeless; Brits with schizophrenia; Brits who are unemployed; Brits who 
are employed; Obese Brits. This measure has previously been used to investigate explicit 
dehumanisation of population groups such as people who have  mental health problems; those 
with experiences of homelessness  people involved in criminality; minority ethnic, cultural, 
and religious groups; and predicts both hostility towards targets, and support for punitive 
polices (Kteily and Bruneau, 2017; Bruneau et al., 2018; Boysen et al., 2020). Comparison 
groups were chosen on the basis of representing groups that are less- or similarly stigmatised 
compared to people who use heroin (e.g. Kersbergen and Robinson, 2019; Ktiely et al., 2015; 
Sattler et al., 2017).  
 
Subtle dehumanisation was assessed using an adapted version of the emotion attribution task 
used by Kersenberger and Robinson (2019) in their study of attitudes towards obesity. 
Participants were asked to indicate on a 100-point slider (Not well at all to Very well) how well 
each of 16 emotions (presented at random) characterised UK citizens who use heroin; and three 
comparison groups, UK citizens; UK citizens who use cannabis; and UK citizens who are 
homeless (presented at random). Included emotions were classed as primary or secondary, and 
as positive or negative. Primary emotions are considered universal to all humans and non-
human animals, and those included were anger; disgust; euphoria; fear; happiness; joy; 
pleasure; and sadness. Secondary emotions are considered uniquely human and those included 
were admiration, guilt, hope, love, remorse, resentment, shame, and tenderness. Lower 
endorsement of secondary emotions represents greater subtle dehumanisation. An advantage 
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of this measure is that participants are less aware that choice of attributes is an indicator of 
target group dehumanisation (Haslam and Loughnan, 2014).  
 
Additional measures  
Moral disgust was assessed using the seven-item subscale of the Three Domains of Disgust 
Scale (TDDS), which assesses disgust that motivates the avoidance of social-norm violators. 
(Tybur, Lieberman and Griskevicius, 2009). Item were scored on a Likert scale (0 Not 
disgusting at all, to 6 Extremely disgusting) with higher scores representing greater disgust.  
Cronbach’s  = 0.84, indicating a good level of internal consistency.  
 
The Disgust Scale Revised (DS-R) was used to measure individual differences in sensitivity to 
general disgust (Olatunji et al., 2007). It comprises 25-items, with items 1 to 13 scored True 
(1) or False (0), and the remainder as Not (0), Slightly (0.5), or Very (1) disgusting. Disgust 
sensitivity is scored by calculating by summing the responses to all 25 items, with higher scores 
representing greater disgust sensitivity. Cronbach’s  = 0.80, indicating an acceptable level of 
internal consistency. 
 
We assessed participant support for five non-discriminatory drug policies (Making people pay 
extra for their own NHS treatment where their illness is caused by their illegal drug use; 
Prescribing heroin on the NHS to people who are addicted to the drug; Making payment of 
benefits to people who are addicted to drugs dependent on them attending drug treatment 
services; Provide all people who have problems with drugs access to free drug treatment; 
Provision of a facility where people can inject illegal drugs under the supervision of a doctor, 
nurse, or other healthcare professional). These items were randomly presented alongside 
seven other health and social policy filler items.  Each item was scored from 1 (No support at 
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all) to 10 (Complete support), with higher total scores (with appropriate reverse scoring) 
representing greater support. Cronbach’s  = 0.74, indicating an acceptable level of internal 
consistency. 
 
Attitudes towards people who are homelessness were assessed through three questions taken 
from the Scottish Social Attitudes Survey General Attitudes to Homeless Module (The Scottish 
Government, 2006). These were Most homeless people have just been unlucky in their lives; 
Most homeless people could find somewhere to live if they really tried (reverse scored); Many 
people say they are homeless just to try and get a house from the council (reverse scored). 
Questions were scored on a Likert scale (1 Strongly Disagree to 5 Strongly agree), with higher 
scores representing more positive attitudes. In the present study, Cronbach’s  = 0.81, 
indicating a good level of internal consistency. 
 
Attitudes towards people with substance use disorders (hereafter attitudes towards people in 
recovery) were assessed through 19 questions taken from a public attitudes to drugs survey 
(Singleton, 2010), originally adapted from the Attitudes to Mental Illness survey (Singer et al., 
2016), and utilised in the 2016 Scottish Government’s Public Attitudes Towards People with 
Drug Dependence and People in Recovery survey (The Scottish Government, 2016). Questions 
were scored on a five-point Likert scale (1 Strongly Agree to 5 Strongly disagree) and assessed 
attitudes towards people with a history of drug dependence (e.g. Parents should not let their 
children play with the children of someone with a history of drug dependence (reversed scored); 
People with a history of drug dependence are too often demonised in the media). Higher total 
scores represented more negative attitudes. In the present study, Cronbach’s  = 0.89, 
indicating a good level of internal consistency. 
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Stigmatising attitudes towards PWUD was assessed using a version of the 9-item Attribution 
Questionnaire (AQ-9; Corrigan et al., 2003), previously adapted for use in a study assessing 
stigma towards PWUD (Sumnall et al., 2020b). The scale was worded to aid understanding for 
non-specialists, and included items across subdomains of lack of pity (Do you feel pity for 
people with drug dependence?; reversed scored); dangerousness (How dangerous do you feel 
people with drug dependence are?); fear (How scared of people with drug dependence do you 
feel?); blame (Do you think that it is people with drug dependence's own fault that they are in 
their present condition?); segregation (Do you think it is best for the communities of people 
with drug dependence if they are confined in a hospital?); anger (How angry do you feel at 
people with drug dependence?); avoidance (Would you try to stay away from people with drug 
dependence?); coercion (How much do you agree that people with drug dependence should be 
forced into drug treatment even if they do not want to?); and failure to help (How likely is it 
that you would want to help someone with drug dependence?; reversed scored). Individual 
items are scored on a nine-point Likert scale (1 not at all to 9 very much), and a total stigma 
score calculated (range 9-81). Higher scores represent higher total stigmatising attitudes. In 
this study, Cronbach’s  = 0.80, indicating a good level of internal consistency. 
 
Participants were also asked to indicate if i) they; and ii) a family member/close friend, had 
ever received drug treatment (coded 0 = no; 1 = yes). Finally, they self-rated their knowledge 
of the reasons why some people developed problems with substances and others do not (10-
point scale; From 1 = No knowledge to 10 = most knowledge), and if they had seen media 
reports about people who have experienced problems with substances in the previous six 
months. Those who positively endorsed this item were asked whether they judged these to be 
supportive, negative, or balanced in their representation of PWUD. 
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To assess differences in AOH scores between the heroin, cannabis, and reference groups we 
used Friedman’s test for non-parametrically distributed data, followed by Wilcoxon signed 
rank test with Bonferroni correction for multiple comparisons. 
 
To assess differences in subtle dehumanisation we undertook a 2 (Emotional valence: positive, 
negative) x 2 (Emotion level: primary, secondary) x 2 (group; ‘Brits’, ‘Brits who use heroin’) 
repeated measures ANOVA, followed by post hoc paired samples t-tests corrected for multiple 
comparison. We repeated the analyses to assess differences in subtle dehumanisation between 




We undertook two exploratory analyses. Firstly, to assess the utility of dehumanisation as a 
predictor of stigmatising attitudes we correlated AOH and subtle dehumanisation with AQ-9 
scores. Secondly, we undertook hierarchical linear regression with score for non-
discriminatory drug policy as the dependent variable. For both analyses we first calculated 
(unstandardised) residual change scores for i) AOH ratings for ‘Brits who use heroin’ predicted 
by ratings for ‘Brits’; and ii) secondary emotion attributions for ‘Brits who use heroin’ 
predicted by ratings for ‘Brits’. Lower residual scores indicated greater blatant or subtle 
dehumanisation of heroin (i.e., greater dehumanisation compared to the reference group).  
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For prediction of policy support, residual change scores were entered into block 1; 
demographics and political orientation were entered into block 2; TDDS and DS-R scores were 
entered into block 3; and scores for attitudes towards people who are homeless, people in 
recovery, AQ9, self-rated knowledge about substance use, and personal experience of 
treatment or knowing someone who had received treatment were all entered into block 4.  
 
These covariates were chosen on the basis of previous research showing associations between 
these views, contact with people who use substances, or familiarity with drug-related topics on 
stigma (Addison and Thorpe, 2004; Corrigan, Kuwabara and O'Shaughnessy, 2009; Brown, 
2011; Lloyd, 2013; Sattler et al., 2017; Goodyear, Haass-Koffler and Chavanne, 2018). Those 
holding conservative and right-wing values have also been shown to dehumanise more than 
other political orientations (DeLuca-McLean and Castano, 2009; Haslam and Loughnan, 
2014).  Although dehumanisation, stigmatisation, and disgust are distinct concepts (Kteily and 
Bruneau, 2017), the latter two predict dehumanisation, and so we also included measures of 
these (Dalsklev and Kunst, 2015).  
 
Alpha was set at .05, and all analyses were undertaken with SPSS V27 (IBM Corp, 2020). Our 









There was a statistically significant difference in AOH blatant dehumanisation score depending 
upon the target group, χ2(10) = 282.247, p = 0.000. Post-hoc analysis with Wilcoxon signed-
rank tests (Bonferroni correction for 10 comparisons), indicated significant score differences 
between AOH rating for the heroin group and Brits (Z = -7.455, p = 0.000); Arabs (Z = -6.867, 
p = 0.000); Brits who use cannabis (Z = -6.399, p = 0.000); Brits with cancer (Z = -8.301, p = 
0.000); Mixed race Brits (Z = -8.455, p = 0.000); Brits who are homeless (Z = -7.031, p = 
0.000); Brits with schizophrenia (Z = -5.973, p = 0.000); Brits who are unemployed (Z = -6.966, 
p = 0.000); Brits who are employed (Z = -8.299, p = 0.000); Obese Brits (Z = -5.802, p = 0.000). 
Heroin users were therefore rated as being less evolved than all other reference groups, 
including the cannabis group. 
 
To assess whether this was a heroin specific effect, we repeated the post-hoc analysis 
comparing cannabis to other reference groups. There were no significant differences in ranks 
(all p > 0.05 after  Bonferroni correction applied). 
 
Subtle dehumanisation 
i) Brits vs heroin: we found a significant group (Brits vs heroin) effect (F(1,306) = 
110.89, p < .001, η2p = .25), and significant group x emotion level (primary, secondary) 
(F(1,306) = 18.15, p < 0.001, η2p = .06); group x valence (positive, negative) (F(1,306) = 




Post-hoc paired samples t-tests (Figure 1) showed that participants thought that the 
heroin group were significantly less likely to feel secondary emotions (t(306) = -7.24, p < .001, 
dz = 0.51) than Brits. Examining emotional valence, they were rated as less likely to feel 
primary positive (t(306) = -10.88, p < .001, dz = .62), and secondary positive (t(306) = -22.69 
p < .001, dz = 1.30) emotions, and more likely to feel primary negative (t(306) = 2.31, p = 0.02, 
dz = 0.13) and secondary negative emotions (t(306) = 6.73, p < .001, dz = 0.38).  
 
ii) Cannabis vs heroin: we did not find a significant group (cannabis vs heroin) effect 
(F(1,306) = 0.286, p < .593, η2p = .00), but there were significant group x emotion level 
(primary, secondary) (F(1,306) = 15.48, p < 0.001, η2p = .05) and group x valence (positive, 
negative) (F(1,306) = 510.92, p < .001, η2p = .63) interactions. However, there was no group x 
level x emotion (F(1,198) = .177, p =.674, η2p = .00) interaction. Accordingly, no follow up 
post-hoc tests were performed. 
 
iii) Homeless vs heroin: we found a significant group (homeless vs heroin) effect (F(1,306) 
= 4.613, p = 0.03, η2p = .02), and significant group x emotion level (primary, secondary) 
(F(1,306) = 217.70, p < 0.001, η2p = .42); group x valence (positive, negative) (F(1,306) = 
58.79, p < .001, η2p = .16); and group x level x emotion (F(1,198) = 490.31, p < .001, η2p = 
.62) interactions. 
 Post-hoc paired samples t-tests showed that participants thought that the heroin group 
were significantly less likely to feel secondary (t(306) = -5.82, p < .001, dz = 0.33) emotions 
than homeless. They were rated as more likely to feel primary positive (t(306) = 18.45, p < 
.001, dz = 1.05) emotions, and less likely to feel primary negative (t(306) = -6.61, p < .001, dz 
= 0.38) and secondary positive emotions (t(306) = -10.29, p < .001, dz = 0.59). There was no 




There were significant correlations between residual blatant (r = -.323, p < 0.001) and subtle (r 
= -.157, p < 0.05) dehumanisation and AQ-9 score. Higher dehumanisation of people who use 
heroin relative to the general population was associated with higher stigmatising attitudes. As 
shown in Table I, there were significant correlations between blatant dehumanisation and all 
AQ-9 items, and secondary dehumanisation and lack of pity, blame, anger, and avoidance. 
 
INSERT TABLE I HERE 
 
The regression analysis predicting supportive drug policy support scores, and model 
parameters are presented in Table II. Model 1 accounted for the largest proportion (17.3%) of 
the variance in support for drug policy, demonstrating the importance of blatant 
dehumanisation and emotion. The final model was statistically significant R2 = .483; F (16,115) 
= 6.726, p < .001. Across all steps, younger age, lower blatant dehumanisation, and lifetime 
use of any controlled drug predicted greater support for supportive drug policy ( = .38, p < 
0.001;  = .21, p < 0.05;  = .17, p < 0.05 at Step 4, respectively). 
 
INSERT TABLE II HERE
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Discussion 
We investigated whether there was dehumanisation towards people who use heroin in a general 
population sample. Our main study hypotheses were supported, and we found that there was 
blatant dehumanisation, and that this group were viewed as less human than reference groups, 
including the general population and other stigmatised groups such as those who are homeless, 
have serious mental health problems, or who are obese. We also found lower ratings of 
humanness compared to people who use cannabis, suggesting that these attitudes may not 
extend to all PWUD, but only to users of certain substances. We also found evidence of subtle 
dehumanisation (i.e. infrahumanisation). When compared to a general British population 
reference group, people who use cannabis, or people who are homeless, participants rated 
people who use heroin just as likely to feel primary emotions common to all animals, but less 
likely to experience uniquely human secondary emotions. Finally, in our exploratory analyses 
we found that dehumanisation predicted stigmatising attitudes, and after controlling for a range 
of relevant demographic, stigma, and disgust variables, lower blatant dehumanisation of people 
who use heroin relative to the general population, younger age, and personal use of controlled 
substances predicted greater support for non-discriminatory drug policy. 
 
There is a large body of research that suggests that dehumanisation of out-groups is prevalent 
across cultures, population characteristics, social identities, and medical diagnoses (Kteily and 
Bruneau, 2017), but our work is one of the few that has examined this in relation to PWUD, 
and more specifically heroin use. Our findings extend previous research that has consistently 
found that diverse groups, including the general public, and law enforcement, health and social 
care professionals, stigmatise PWUD (Lloyd, 2013), or blatantly dehumanise them (Harris and 
Fiske, 2006; Boysen et al., 2020; Fontesse, Rimez and Maurage, 2021). As we found 
differences in dehumanisation scores towards heroin and cannabis users compared to reference 
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groups, our study confirms previous research, including survey and qualitative research, that 
suggests stigmatising attitudes are drug dependent, and are not simply a function of the use of 
controlled substances (e.g. McElroy, 2001; Palamar et al., 2017). For legally regulated and 
socially-normalised substances such as alcohol, stigmatisation is orientated towards people 
with use disorders or harmful use (Kilian et al., 2021). As more countries establish legal 
(medical and non-medical) markets for cannabis, within-substance attitudes, including 
dehumanisation, may similarly shift towards transgressions of newly emerging normative use 
behaviours, rather than use per se (Asbridge et al., 2016). We replicated previous findings on 
blatant dehumanisation, but also found evidence of subtle dehumanisation, which was 
associated with stigmatising attitudes of lack of pity, and increased blame, anger, and 
avoidance of PWUD, which might underlie processes of dehumanisation. Across all out-
groups, dehumanisation also acts as a barrier to positive social interaction, and target groups 
are perceived as a threat to the in-group, whether directly through aggression or violence, or 
by challenging in-group integrity and identity, including moral equanimity (Leyens et al., 2007; 
Haslam and Loughnan, 2014).  
 
While there are many psychological factors that contribute to stigmatising attitudes 
(Markowitz and Slovic, 2020), one socio-moral factor suggested to have a role dehumanisation 
is disgust, where neural responses have indicated dehumanised social groups elicit disgust 
responses in the amygdala and insula (Harris and Fiske, 2006). Disgust has been defined as a 
defensive mechanism evolved to protect from harm by promoting withdrawal from food 
contaminants (Vicario et al., 2017), though disgust has also been observed in relation to non-
food stimuli suggesting that it has a more wide-ranging protective function that extends to 
interpersonal and social interactions (Rozin, Haidt and McCauley, 1993). Moreover, stigma 
and disgust have been found to be strongly related to each other. In one fMRI study, comparing 
 20 
activation to stigmatised faces (obesity, facial piercings, transsexual, and unattractive 
categories) and control faces, control faces were rated as significantly less disgusting than all 
other categories (Krendl et al., 2006). According to Rozin and colleagues (1999), the law of 
contagion dictates that stimuli that have been in contact with individuals who are deemed 
unwell (e.g. individuals with mental health problems, cancer patients) are viewed with disgust 
for fear that they may make the viewer similarly ill. Disgust propensity (how likely a person is 
to be disgusted), has also been found to be related to stigma towards homosexuality (Olatunji, 
2008), obesity (Vartanian, 2010), and cancer patients (Pryor et al., 2004) while disgust 
sensitivity (how strong a disgust response is) has been shown to predict avoidance behaviour 
to anxiety provoking stimuli (Nicholson and Barnes-Holmes, 2012). Sherman and Haidt (2011) 
discuss the relationship between animalistic dehumanisation and disgust, and the role of 
mentalising (the processes used to decide if an entity possesses a mind). They propose that 
elicitors (things which elicit disgust) that remind us of our animal nature (e.g., elicitors related 
to sex or death) are most likely to elicit a disgust response and inhibit the processes involved 
in mentalising. Disruption of mentalising therefore leads us to attribute fewer human traits to a 
group that we perceive as disgusting. This animalistic dehumanisation results in exclusion of 
the disgust-eliciting and dehumanised group from social interactions, in an attempt to reduce 
the potential contamination.   
 
Dehumanisation may also be used as a self- or in-group strategy of moral disengagement in 
order to maintain group self-image (Bandura, 1991; Bandura et al., 2001). Actions that 
potentially have negative consequence for others may lead to feelings of guilt and regret, and 
anticipation of these may lead to self-regulation of behaviour (Bandura, 1991). However, 
psychosocial mechanisms of disengagement, including dehumanisation of affected groups, 
allow group members to violate moral norms with emotional impunity by providing 
 21 
justification, rationalisation, and/or absolvement of personal responsibility. Once out-group 
members are dehumanised and stripped of common human attributes, even when undertaken 
subtly and unintentionally, empathy towards them is reduced, opening them to hostility and 
discrimination (Čehajić, Brown and González, 2009; Boysen et al., 2020). Whilst previous 
research has examined how this might relate to overtly aggressive policies towards groups such 
as refugees, or those states perceived as hostile (e.g. Rai et al., 2017), these types of process 
may also be relevant to health, criminal justice, and social care policy decisions. Subtle 
dehumanisation of people with mental health problems, for example, predicts increased public 
social distancing and perceptions of dangerousness (Martinez et al., 2011; Martinez, 2014; 
Krzyzanowski, Howell and Passmore, 2017); blatant dehumanisation of people with obesity 
predicts public support for discriminatory policies (Kersbergen and Robinson, 2019); whilst 
dehumanisation of people with alcohol use disorders by healthcare workers has been associated 
with negative outcomes such as reduced value paid to patient consent and pain when making a 
medical decision related to their treatment (Fontesse, Rimez and Maurage, 2021). Policy 
makers may take advantage of public perceptions towards out-groups to justify difficult 
political choices, subsequently reinforcing and maintaining the social contexts that originally 
shaped those attitudes (Harris, 2014). Recent changes in the objectives of UK drugs policy and 
reduction in expenditure (Roscoe et al., 2021), for example, have been accompanied by changes 
in framing of responses to substance use and the people who use them, with suggestions that 
PWUD are denied human agency in both popular and political discourse (Stevens, 2018; 
Atkinson and Sumnall, 2021). Some recent UK public opinion surveys commissioned by 
campaigning groups suggest that public attitudes towards responses to controlled substance use 
might be changing (YouGov and CDPRG, 2019). However, despite this, and the high burden 
of societal harms associated with substance use, most studies suggest only minority support for 
public expenditure on drug treatment (Matheson et al., 2014), and high public opposition 
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towards evidence based harm reduction, even during public health events such as the US opioid 
overdose crisis (McGinty et al., 2018; McGinty and Barry, 2020). Considering the association 
we found between blatant dehumanisation and lower support for non-discriminatory drug 
policy, dehumanisation could be being employed as a moral disengagement strategy to 
rationalise lack of support, or dehumanising attitudes might simply precede lower support. 
Follow up work incorporating moral disengagement measures could help to resolve this, as 
addressing dehumanisation as a moral disengagement strategy would require a different 
approach to stigma reduction actions (Livingston et al., 2012; Sumnall et al., in press).  
 
Indeed, in contrast to stigma research there has been little work examining reduction of 
dehumanisation of out-groups labelled on the basis of health or social behaviours (cf refugees 
or ethnicity) (Haslam and Loughnan, 2014; Lancaster, Seear and Ritter, 2017). However, in 
keeping with the findings of stigma research, there is a small body of evidence to suggest 
interventions designed to improve the quality of contact between groups, including those 
receiving welfare payments, have been shown to be effective in reducing dehumanisation 
(Vezzali et al., 2012; Corrigan, 2016; Kteily and Bruneau, 2017; Bruneau et al., 2021). Whilst 
these are approaches that can be relatively easily embedded within professional education or 
through small structured inter-group contact activities (Couture and Penn, 2003; Corrigan et 
al., 2014; Bruneau et al., 2021), as with all public health interventions, they may be difficult to 
implement at scale (World Health Organization, 2009). These types of approach may also face 
some additional challenges. Rather than particular behaviours or perceived characteristic 
leading to beliefs that out-groups are simply ‘less than human’, dehumanising attitudes may 
reflect automatic perceptions that out-groups deserve low social hierarchical status, with 
foundations in long-standing inter-group interactions, and individual and societal attitudes 
towards intersecting factors such as class, ethnicity, and gender (Haslam and Loughnan, 2014), 
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and beliefs about the blame and controllability of substance use disorders, and the 
dangerousness of PWUD (Corrigan, Kuwabara and O'Shaughnessy, 2009; Sattler et al., 2017; 
Ashford, Brown and Curtis, 2018; Sumnall et al., 2021). Furthermore, in accordance with social 
dominance theory, those who dehumanise may not simply perceive others as threatening, but 
may value asserting power and support efforts to separate groups through the use of 
discriminatory policy and other prejudicial actions, and are therefore less likely to respond to 
humanising interventions  (Pratto, Sidanius and Levin, 2006; Markowitz and Slovic, 2020).  
 
Acknowledging these challenges, one approach to humanisation could be through addressing 
popular media representations of PWUD (Fraser et al., 2016; McGinty, Kennedy-Hendricks 
and Barry, 2019). PWUD are typically framed in popular media as dangerous, ‘contaminated’, 
and lacking human agency (Atkinson and Sumnall, 2018; Atkinson and Sumnall, 2021), but 
previous work has shown that manipulations such as sympathetic framing and the use of neutral 
and person first terminology is associated with reduced stigma (Goodyear, Haass-Koffler and 
Chavanne, 2018; Sumnall et al., 2021). This is an area that requires further research with 
respect to dehumanisation. Of relevance, when research participants were asked to read a news 
article depicting a violent crime depicted by a man with a diagnosis of schizophrenia, they were 
much more likely to select noun-labelled headlines (e.g., ‘Schizophrenic Snaps’) than person-
first ones (e.g., ‘Person with Schizophrenia Snaps’), and this was mediated by dehumanising 
attitudes (Krzyzanowski, Howell and Passmore, 2017). However, another experimental 
intervention designed to reduce dehumanisation of people with obesity by presenting textual 
information on its complex causes was unsuccessful, as it may have reinforced existing norms 
that most people already dehumanise obesity, thus legitimising discriminatory attitudes 
(Kersbergen and Robinson, 2019). As people process information about in- and out-group 
members differently (Riek, Mania and Gaertner, 2006), these researchers suggested that 
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combining explanatory information with humanising imagery that contrasted with typical 
media representations of obesity (i.e. a focus on headless bodies, comparable to ‘mugshots’ 
and images of drug overdose or extreme intoxication in relation to substance use) warrant 
further investigation. Other work in the alcohol and mental health fields suggests that 
presentation of conditions on a continuum, which suggests that people all experience relevant 
symptoms at some point in their life, rather than as a binary, where experiences are presented 
as different from normative human experiences, is associated with reduced stigma (Peter et al., 
2021). This type of framing may increase perceived similarities between groups, thus reducing 
inter-group boundaries. However, whilst all humans may be susceptible to mental health 
problems, and in many countries a majority report recent use of alcohol, only a minority use 
drugs such as heroin (e.g. approximately 0.5% of the UK population report a lifetime use; ONS 
2020). Therefore, a focus on other overlapping human characteristics rather than experiences 
of substance use may be more appropriate.  
 
This study has limitations which should be acknowledged, and which also suggest some areas 
of further work. Firstly, we recruited a convenience sample and so our findings may not be 
generalisable to the wider population; our study was also cross-sectional and so we do not make 
any claims about causality. Whilst this sampling method led to over-representation of females 
and participants with at least one lifetime use of a controlled substance, follow up analysis 
suggested no differences in blatant and subtle dehumanisation using these grouping variables 
(data not shown), and they were not significant predictors of policy support. Secondly, whilst 
we controlled for moral disgust and stigma towards PWUD in our exploratory analysis, we 
were unable to control for stigmatising attitudes towards the target and reference groups in our 
assessments of blatant and subtle dehumanisation. Whilst stigma is considered distinct from 
dehumanisation (although related concepts) (Bruneau et al., 2018), pre-existing negative 
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attitudes towards depicted groups may have influenced our findings. However, study objectives 
were only revealed in the debrief, and whilst participants may have guessed that the images 
used in the AOH meant we were assessing ‘humanness’, thus potentially introducing social 
desirability biases, the nature of the subtle dehumanisation task would not be immediately 
clear. Participants would be unlikely to be aware that their ratings of randomly presented 
emotional attributes indicated dehumanisation of target groups (Eyssel and Ribas, 2012). The 
heroin group was also rated as feeling significantly more negative primary and secondary 
emotions, suggesting that subtle dehumanization can be further distinguished through valence 
of emotions, and does not simply reflect dislike or antipathy. Thirdly, we only presented simple 
group labels (e.g. heroin user). Work on public stigmatisation of PWUD suggests that 
substance use intersects with other (perceived) characteristics including gender, age, ethnicity, 
deprivation and social class  (Ahern, Stuber and Galea, 2007; Radcliffe and Stevens, 2008; 
Järvinen and Demant, 2011; Kulesza, Larimer and Rao, 2013; Smith et al., 2016; Sattler et al., 
2017). Other research suggests that groups attributed with these characteristic are 
independently dehumanised across cultures (e.g. (Rudman and Mescher, 2012; Loughnan et 
al., 2014; Kteily et al., 2015), and so future work could investigate how representation of 
additional characteristics of people who use heroin affect dehumanising attitudes. Finally, 
whilst we included some individual participant predictors (e.g. demographics, social distance 
to PWUD, personal experiences of substance use), other psychological and social predictors 
such as personality (e.g. narcissism), self-perception of social power, status and vulnerability, 
and adverse childhood experiences that lead to lower social connectedness, have been 
associated with dehumanising attitudes (Markowitz and Slovic, 2020). Better understanding of 
these factors may assist in framing and targeting actions that aim to reduce stigma and 





In conclusion, we found evidence that there was blatant and subtle dehumanisation of people 
who use heroin. In this sample, this was even greater relative to other highly stigmatised 
groups. Dehumanisation of people who use heroin may present significant challenges for the 
development of stigma reduction initiatives, and subsequently in fostering public support for 
evidence-based drug policy and treatment. As public opinion plays an important role in policy 
discussions, denial of the humanity of this group could be used to justify discriminatory policies 
or relative deprioritisation of support services in funding decisions. Person-centred activities 
that seek to ‘humanise’ people who use drugs, including social inclusion, and encouraging 
compassionate media representations that portray the lived experiences of substance use are 
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Figure 1 Extent to which participants attributed primary (universal) and secondary (uniquely 
human) emotions to the Brits and Heroin groups, split by emotional level and valence. Bars 
represent means and 95% CI. *** p < .001; * p < 0.05. 
 
Table I Correlations between residual blatant and subtle dehumanisation scores and AQ-9 items. * < p < 0.05; ** p < 0.01; *** p < 0.001 
 1 2 3 4 5 6 7 8 9 10 
1. Blatant           
2. Subtle 0.18** —         
3. Lack of pity 0.23** 0.22** —        
4. Dangerousness -0.33*** -0.13 0.07 —       
5. Fear -0.30*** -0.13 0.07 0.74*** —      
6. Blame -0.32*** -0.27*** 0.35*** 0.50*** 0.51*** —     
7. Segregation -0.26*** -0.05 0.06 0.48*** 0.45*** 0.45*** —    
8. Anger -0.25*** -0.21** 0.22** 0.47*** 0.52*** 0.56*** 0.40*** —   
9. Avoidance -0.32*** -0.18* 0.08 0.68*** 0.58*** 0.54*** 0.49*** 0.56*** —  
10. Coercion -0.26*** -0.14 0.03 0.40*** 0.43*** 0.40*** 0.29*** 0.48*** 0.38  




Table II Summary of linear regression for variables predicting support for drug policy; * < p 
< 0.05; ** p < 0.01; *** p < 0.001. (R2 step 1 = .173;  R2 step 2 = .227,  R2 step 3 = .01,  
R2 step 4 = .07; p <0.05). 
 
 
Variable B SE   
Step 1    
Intercept 31.04 .75  
Blatant 
dehumanisation  
.13 .03 .38*** 
Secondary emotion .08 .05 .12 
Step 2    
Intercept 21.95 2.263  
Blatant 
dehumanisation  
.09 .03 .27*** 
Secondary emotion .08 .05 .13 
Age .29 .07 .34** 
Participant Gender 
(ref = male) 
.36 1.60 .02 
Education (ref < 
degree) 
3.57 1.56 .19* 
Voting (ref = left 
wing) 
   
Right -3.11 1.96 -.13 
Centre 1.73 3.88 .03 
Step 3    






Secondary emotion .08 .05 1.21 
Age .31 .07 .37** 
Participant Gender 
(ref = male) 
.56 1.61 .03 
Education (ref < 
degree) 
3.24 1.60 .17* 
Voting (ref = left 
wing) 
   
Right -2.95 1.97 -.11 
Centre 1.73 3.95 .03 
TDDS -.11 .08 -.10 
DSR .22 .34 .05 
Step 4    
Intercept 11.16 12.16  
Blatant 
dehumanisation  
.07 .03 .21* 
Secondary emotion .05 .03 .08 
Age .32 .07 .38*** 
Participant Gender 
(ref = male) 
.60 1.65 .03 
Education (ref < 
degree) 
2.53 1.58 .14 
Voting (ref = left 
wing) 
   
Right -2.48 1.94 -.09 
Centre -1.05 3.95 -.02 
TDDS -.10 .08 -.09 
DSR .30 .34 .07 
AQ-9 -.09 .07 -.10 
Attitudes to 
Homelessness  
-.39 .39 -.08 
Attitudes to 
Recovery 
.05 .13 .03 
Self-reported 
knowledge 
.57 .38 .12 
Ever used a 
controlled substance 
10.30 4.65 .17* 
Received drug 
treatment - Family 
member/close friend 
-.99 1.39 -.05 
Received drug 
treatment - self 
-1.23 5.82 -.02 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
